Professor LIU Minru's Medication Rule in Treatment of Polycystic Ovary Syndrome （Intracellular Lipid Membrane Congestion Syndrome）

HE Xinbo; HU Xiang; LIU Minru; LI Fuzhu; HUANG Yuhuan

doi:10.13422/j.cnki.syfjx.20242097

Your Location：

Home >

Browse articles >

Professor LIU Minru's Medication Rule in Treatment of Polycystic Ovary Syndrome （Intracellular Lipid Membrane Congestion Syndrome）

Updated：2024-09-12

Previous|Next

- Professor LIU Minru's Medication Rule in Treatment of Polycystic Ovary Syndrome （Intracellular Lipid Membrane Congestion Syndrome）
  Enhanced Publication
- “Professor Liu Minru has made new progress in the treatment of polycystic ovary syndrome. Through data mining and network pharmacology methods, she has revealed her medication patterns and core prescriptions, providing new ideas for the treatment of polycystic ovary syndrome.”
- HE Xinbo , HU Xiang , LIU Minru , LI Fuzhu , HUANG Yuhuan
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 20, Pages: 169-176(2024)
- Affiliations：
  1.Hospital of Chengdu University of Traditional Chinese Medicine（TCM），Chengdu 610032，China
  2.Chengdu University of TCM，Chengdu 610075，China
  3.Shanghai Daosheng Medical Technology Co. Ltd.，Shanghai 201203，China
- Author bio：
- Funds：
- DOI： 10.13422/j.cnki.syfjx.20242097
  CLC：
- Accepted：
Scan QR Code
DOI：
DOI：

AI Introduction
Full Text(HTML)
Figs( 0 ) Tabs( 2 )
References
Publication Info
Metrics

405

Views

904

Downloads

1

CSCD

Alert me when the article has been cited

Submit

Tools

BibTeXDownload
EndnoteDownload
RefMan Download
NoteExpressDownload
NoteFirstDownload

Publicity Resources

Related Articles

Bioinformatics Reveals Mechanism of Zuoguiwan in Treating Polycystic Ovary Syndrome

Pharmacological Effect of Glycyrrizae Radix et Rhizoma Compatibility and Its Mechanism

Chemical Components and Mechanism of Qiling Wenshen Formula in Treating Polycystic Ovary Syndrome

Medication Regularity for Chronic Renal Failure and Underlying Mechanism Based on Data Mining， Network Pharmacology， and Molecular Docking

Effect of Shengui Jiangtang Formula on Glucose and Lipid Metabolism in Type 2 Diabetic db/db Mice via PI3K/Akt/FoxO1 Signaling Pathway and Underlying Mechanisms

Related Author

ZHANG Jinrong

LI Haotian

HUANG Hongming

DENG Ali

ZHAO Min

Zeyu LI

Erwei HAO

Hui LI

Related Institution

School of Basic Medical Sciences， Hubei University of Chinese Medicine

Affiliated Hospital of Hubei University of Chinese Medicine

ASEAN Joint Laboratory for International Cooperation in Traditional Medicine Research，Guangxi University of Chinese Medicine

Guangxi Key Laboratory of Efficacy Study on Chinese Materia Medica， Guangxi University of Chinese Medicine

Wangjing Hospital， China Academy of Chinese Medical Sciences

Intro

Map

Chat

Professor LIU Minru's Medication Rule in Treatment of Polycystic Ovary Syndrome （Intracellular Lipid Membrane Congestion Syndrome）

DOI： 10.13422/j.cnki.syfjx.20242097

AI Introduction

Full Text(HTML)

Figs( 0 ) Tabs( 2 )

References

Publication Info

Metrics

摘要

Abstract

关键词

Keywords

references